1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. Lupin Acquires Symbiomix Therapeutics

M&A Deal Summary

Lupin Acquires Symbiomix Therapeutics

On October 11, 2017, Lupin acquired life science company Symbiomix Therapeutics for 150M USD

Acquisition Highlights
  • This is Lupin’s 7th transaction in the Life Science sector.
  • This is Lupin’s largest (disclosed) transaction.
  • This is Lupin’s 3rd transaction in the United States.
  • This is Lupin’s 3rd transaction in New Jersey.

M&A Deal Summary
Date 2017-10-11
Target Symbiomix Therapeutics
Sector Life Science
Buyer(s) Lupin
Deal Type Add-on Acquisition
Deal Value 150M USD

Target

Symbiomix Therapeutics

Newark, New Jersey, United States
Symbiomix Therapeutics is a privately held company focused on bringing innovative therapies to market for gynecologic infections that can have serious health consequences. Symbiomix Therapeutics was founded in 2012 and is based in Newark, New Jersey.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Lupin

Mumbai, India
Category Company
Founded 1968
Sector Life Science
Employees24,006
Revenue 221.9B INR (2025)
DESCRIPTION

Lupin is an innovation-led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products. Lupin was founded in 1968 and is based in Mumbai, Maharashtra.

DEAL STATS #
Overall 8 of 11
Sector: Life Science M&A 7 of 9
Type: Add-on Acquisition M&A Deals 6 of 7
State: New Jersey M&A 3 of 3
Country: United States M&A 3 of 5
Year: 2017 M&A 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-09 GAVIS Pharmaceuticals

Somerset, New Jersey, United States

GAVIS Pharmaceuticals LLC is a provider of pharmaceutical products in a variety of dosage forms.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-11 Kyowa Pharmaceutical

Osaka, Japan

Kyowa Pharmaceutical is a generic pharmaceutical company and is the domestic provider in the Central Nervous System (CNS) therapeutic area. Kyowa Pharmaceutical was founded in 1954 and is based in Osaka, Japan.

Sell -
Mergr

Solution for

Product

Company

Legal